AKT1 and lung carcinoma: The top 10 target nodes, VEGFA, AKT1, TP53, MMP9, FOS, CASP3, and ADAR (1A, 1B, 2A, and 2C), had a degree value greater than 20, suggesting that these may become the key core targets of PZD for the treatment of lung cancer.